Expertise in
9
conditions

Bader S. Alahmari

Ministry Of National Guard Health Affairs, Riyadh
Riyadh, SA 
Expertise in
9
conditions
Ministry Of National Guard Health Affairs, Riyadh
Riyadh, SA 

Overview

Bader Alahmari practices practicing medicine in Riyadh, Saudi Arabia.

Mr. Alahmari is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Classical Hodgkin Lymphoma, Hemoglobinopathy, Congenital Hemolytic Anemia, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 44 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Ministry of National Guard Health Affairs, Riyadh
Riyadh, Saudi Arabia
Other Locations
Khamis Mushayet, Saudi Arabia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase IIa Study of BL-8040 in Combination With Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma
A Phase IIa Study of BL-8040 in Combination With Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma
Enrollment Status: Terminated
Publish Date: October 31, 2023
Intervention Type: Drug
Study Drugs: BL-8040 CD34-Positive Hematopoietic Cells, Nelarabine
Study Phase: Phase 2
A Pilot Study of Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
A Pilot Study of Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
Enrollment Status: Terminated
Publish Date: February 14, 2022
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Alemtuzumab, Cyclophosphamide, Mycophenolate mofetil, Sirolimus, Fludarabine
Study Phase: Phase 1
View 1 Less Clinical Trial

44 Total Publications

Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort.
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort.
Journal: Journal for immunotherapy of cancer
Published: April 20, 2026

Frequently Asked Questions about Bader S. Alahmari

Is Bader S. Alahmari a top-rated expert for Sickle Cell Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Bader S. Alahmari is classified as an Distinguished expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Bader S. Alahmari participate in research or clinical trials?

Yes. Bader S. Alahmari has published 44 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Bader S. Alahmari's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Alahmari's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile